[Federal Register Volume 68, Number 139 (Monday, July 21, 2003)]
[Notices]
[Page 43166]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-18476]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated March 21, 2003, and published in the Federal 
Register on April 9, 2003, (68 FR 17408), Siegfried (USA) Inc., 
Industrial Park Road, Pennsville, New Jersey 08070, made application by 
renewal to the Drug Enforcement Administration to be registered as a 
bulk manufacturer of the basic classes of controlled substances listed 
below:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Amphetamine (1100).........................  II
Methylphenidate (1724).....................  II
Ambobarbital (2125)........................  II
Pentobarbital (2270).......................  II
Secobarbital (2315)........................  II
Glutethimide (2550)........................  II
Codeine (9050).............................  II
Oxycodone (9143)...........................  II
Hydrocodone (9193).........................  II
Methadone (9250)...........................  II
Methadone-intermediate (9254)..............  II
Dextropropoxyphene, bulk (non-dosage forms)  II
 (9273).
Morphine (9300)............................  II
------------------------------------------------------------------------

    The firm plans to manufacture the listed controlled substances for 
distribution as bulk products to its customers.
    No comments or objections have been received. DEA has considered 
the factors in Title 21, United States Code, section 823(a) and 
determined that the registration of Siegfried (USA) Inc. to manufacture 
the listed controlled substance is consistent with the public interest 
at this time. DEA has investigated Siegfried (USA) Inc. to ensure that 
the company's registration is consistent with the public interest. This 
investigation has included inspection and testing of the company's 
physical security systems, verification of the company's compliance 
with state and local laws, and a review of the company's background and 
history. Therefore, pursuant to 21 U.S.C. 823 and 28 CFR 0.100 and 
0.104, the Deputy Assistant Administrator, Office of Diversion Control, 
hereby orders that the application submitted by the above firm for 
registration as a bulk manufacturer of the basic classes of controlled 
substances listed above is granted.

    Dated: July 2, 2003.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 03-18476 Filed 7-18-03; 8:45 am]
BILLING CODE 4410-09-M